Vertex (VRTX) Soars on Clinical Data and Boosts Biotech Stocks…Updates
Update...3/31/17 Performance %: March and YTD FBT -0.83, +15.87 FBIOX -2.43, +15.79 * Fidelity ahead of IBB in 2017 IBB -3.05,+10.5 QQQ +1.04, +11.73 XBI -2.82, +17.15 XLV -1.9, +7.86 Notable Rayno Portfolio Picks %: March and YTD ABBV +2.9, +4.08 AMGN -8.95, +12.22 BLUE +7,...
Biotech Stocks Sink with Broad Sell-Off on Political Realities…Updates
3/22 Update after close..Relief Rally Awaiting Tomorrow's Vote Large Caps-mostly green with IBB up 0.54%. Mid Caps-some strength RDUS up 3.48% SGEN up 1.74 %, ,TSRO up 4.08%. Small caps XBI up 0.98%. NASDAQ up 0.48%. ========== Biotech Stocks Sink on Trump Comments Uncertainty Mounts for GOP...
Cholesterol Stocks Clobbered: Good Clinical Results But High Expectations
Upbeat Drug Study Data from an Amgen Cholesterol Trial but Stocks are Clobbered Because of Higher Expectations LDL cholesterol is a Toxic Risk Factor Results from a long-term study on the efficacy of a new generation of LDL cholesterol reducing drugs fell short of expectations and clobbered...
Biotech Rally Clipped by Trump Tweet; ACA Makeover Creates Uncertainty…Update-1
Update-1... 10:45 am PST Biotech Rally Resumes tweets on drug pricing are apparently forgotten XBI up 2.63%, IBB up 1.6% Green screen day Smaller cap, clinical stage stocks dominate winners. =========== Trump Tweet Clips Biotech Rally-Drug Pricing Rhetoric Clouds Prospects Again "Trumpcare"...
Rayno BioBeat 2017 #2: Biotech Breakthrough Rally
2017 Biotech Breakthrough on a Green Screen Day Biotech stocks got a second wind today and the 2017 rally broke through recent tops that have been strong resistance. Our favorite trading pick the XBI soared 4.82% to $70.48 breaking through the September top and 19% up YTD. The large cap IBB...